Leaflet Risk Factors Adult
Leaflet Risk Factors Adult
I I I
#PneumoniaA
---
~
-
Vaksinasi efektif mencegah penyakit pneumonia yang - -
disebabkan S. pneumoniae pada pasien. s __ ,, ,,
Berikan vaksinasi pneumonia
pada pasien dengan profil risiko 6 :
• Studi CAPITA menunjukkan vaksin pneumokokus (PCV), seperti
•
• Prevenar 13 (PCV13), efektif mencegah
•
•
• invasive pneumococcal diseases (IPD) sebesar 75°/o.5
•
•
•
•
•
•
•
•
• Pemberian Vaksinasi PCV pada
•
•
: orang dewasa 18 tahun ke atas:
•
*kelompok usia 18-49 th, 50·59 th, dan <! 60 th
•
•
• ~
·-
..·-
**risiko terkena pneumonia pada populasi dewasa •
Referensl:
1. Centers for Disease Control and Prevention (CDC). Pneumocoocal Disease. Transmission and Those at High Risk. Available at:
https:/lwww.cdo.gov/pneumococcal/abouVrlsk-transmlsslon.hlml. Accessed October 2022. 2. Usman Y. et al. Journal of Population and Social Studies.
2019;27(1): 39-52. 3. Kementerlan Kesehatan RI. Laporan Nasional Rlskesdas 2018. https://dlnkes.kalbarprov.go.ld/wp-oontenVuploads/20 19/03/
Laporan-Riskesdas-2018-Naslonal.pdl. Accessed October 05, 2022. 4. Reproduced from [Welte et al, Thorax, volume 67(1), pages 71-79, 2012]
with permission from BMJ Publishing Group Ltd. 2. Lode HM. Resplr Med. 2007;101 (9):1864-1873.5. Bonten MJ, et al. N Engl J Med. 2015;372
(12):11 14-11 2. 6. Pelton SI, et al. BMC Infectious Diseases. 2015;15:470. 7. Latest BPOM Approved Prevenar 13 Local Product Document.
http://labellng.pfizer.com/Showlabellng.aspx?ld=14634
PT Pfizer Indonesia
28"' Floor World Trade Center 3
Kunjungi website Pfizer untuk
JI. Jend. Sudirman Kav.29-3 1,
Tenaga Kesehatan Profesional:
Jakarta 12920, Indonesia
PfizerPro Indonesia
Telp: + 62-21-80861400
PP-PRV-IDN-0228-OCT-2022